Image

ANTI-AGING: HA+GF

HYALURONIC ACID + GROWTH FACTORS

Image

Low Bacterial Load

Registered as cosmetic

Renews the cellular turnover improving the nutritional cycle and skin elasticity

Boosts the results of anti-aging procedures

ReadyMedical Growth Factors are encapsulated in Nanosomes, microspheres that:

PROTECT THEM FROM ENDOGENOUS PROTEASIS

CONSIDERABLY IMPROVE THEIR PENETRATION INTO THE SKIN, MAKING THEM REAL “CARRIERS”

Moreover, this “double layer” structure ensures a very high stability to the molecule.

ANTI-AGING HA+GF

BEFORE & AFTER

recommended combined protocols

TREATMENT/TECHNOLOGY & ACTION

radiofrequency

RM Anti-Aging adds to RF well known tightening effect an immediate improvement of the skin texture and reduces the typical redness due to RF

*Dermaroller, Dermapen, Iontophoresis

Having a remarkable anti-inflammatory action, RM Anti-Aging accelerates the wound closure of the treated cells, plus, the administration of nano-encapsulated GF increases cell motility and improves skin elasticity

*Chemical Peeling, Dermabrasion

RM Anti-Aging provides high hydration and an immediate lenitive action, accelerating skin repair process

MesoJet / JetPeel

After a full MesoJet/JetPeel session RM Anti- Aging provides the skin with a further unique and long-lasting effect that leaves the skin toned up and with a silk-touch effect

Stand alone

After a careful cleaning the application of RM Anti-Aging provides the skin with a strong hydrating anti-aging effect

* It is recommended to apply another RM Anti-Aging during the following 24 h

EFFICACY STUDY ON CELL PROLIFERATION ENHANCEMENT IN HUMAN FIBROBLASTS TREATED WITH READYMEDICAL ANTI-AGING: HA+GF

Human fibroblasts have been treated in vitro with ReadyMedical special compound of sonicated Hyaluronic Acid + Growth Factors with the wound healing technique. After 24 hours the treated cells had increased their motility and proliferation of up to 44%, compared to the untreated cells used as negative controls (1).

Using the inserts, a gap of 500 μm was created in a confluent cell colture monolayer and the wound closure was evaluated by measuring the width of injury line, taking pictures at regular interval of 24 hours.

The effect of the Product ReadyMedical HA + GF was evaluated as the capability of cells to reduce the original gap of 500 μm (100% of wound closure), comparing the pictures, taken at different times with the corresponding pictures of the initial wounded monolayer. The result has been the complete wound closure of the cells treated with ReadyMedical HA + GF after 72 hours.

1) UB-CARE – UNIVERSITY OF PAVIA. Report nr. PRL/17/LC1/P2. Date: 25/07/2017. The full version of this study is available upon request.

Image
Image

ReadyMedical is a JointVenture between :

Image
Image
Image